Prefectural Colony, Kasugai, Aichi 480-03, (M.S., K. K.) Japan. The S-100 protein level in mouse neuroblastoma (N18TG-2 and NIE-l15), rat glioma (C6, C6BU-1, and C6V-1), and hybrid (NG108-15, 140-3, 141-B, NBrlOA, NBr20A, NCB20, and NX31T) cells was determined with a sensitive enzyme immunoassay sy
Regulation of specific functions of glial cells in somatic hybrids. I. Control of S100 protein
✍ Scribed by Philippe Benda; Richard L. Davidson
- Publisher
- John Wiley and Sons
- Year
- 1971
- Tongue
- English
- Weight
- 673 KB
- Volume
- 78
- Category
- Article
- ISSN
- 0021-9541
No coin nor oath required. For personal study only.
✦ Synopsis
Hybrids were isolated between rat glial cells and mouse fibroblasts. Micro complement (C') fixation was used to assay S100, a highly acidic protein specific for nervous tissues, The glial cells contain large amounts of S100. Extracts of the fibroblasts contain some C' fixing material which is detected only at very high protein concentrations and which fixes C' only weakly. The identity of this material is not known. The hybrids contain some C' fixing material, but the concentrations of protein necessary to reach the point of antigen-antibody equivalence is ten times greater with an extract of hybrids than with an extract of glial cells. This increase in the concentration of protein is associated with a decrease in the amount of C' fixed. The possible significance of the C' fixing material in the hybrids is discussed.
📜 SIMILAR VOLUMES
We have studied the role of the 2047 bp 5'-upstream region and 232 bp first exon sequence of the rat Sloop gene in glial specific expression. Sloop luciferase expression vectors carrying serial deletions of the Sloop 5' upstream sequence were constructed and transiently transfected into the peripher
## Abstract “Loss of function” alterations in growth inhibitory signal transduction pathways are common in cancer cells. In this study, we show that growth arrest (GA) treatments—serum and growth factor withdrawal and growth inhibitory IL‐6 family cytokines (Interleukin‐6 and Oncostatin M (OSM))—in